title: Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease.
authors: Amit
authors: A
authors: Batla
authors: Maria
authors: M
authors: Stamelou
authors: Niccolo
authors: N
authors: Mencacci
authors: Anthony H
authors: AH
authors: Schapira
authors: Kailash P
authors: KP
authors: Bhatia
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007211:Indoles; C046649:ropinirole
references: Neurology. 1998 Oct;51(4):1057-62
references: 9781529
references: Prog Neurobiol. 2009 Jan 12;87(1):1-9
references: 18938208
references: Mov Disord. 2007 Dec;22(16):2409-17
references: 17894339
references: N Engl J Med. 2004 Dec 9;351(24):2498-508
references: 15590952
references: J Neurol. 2009 Mar;256(3):390-5
references: 19319462
references: Exp Neurol. 2004 Jan;185(1):36-46
references: 14697317
references: N Engl J Med. 2000 May 18;342(20):1484-91
references: 10816186
references: Mov Disord. 2005 Mar;20(3):342-4
references: 15580606
references: Mov Disord. 1998 Mar;13(2):234-41
references: 9539335